rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    HLN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Haleon (LSE:HLN) Faces Weaker Returns, Does The Fair Value Case Still Hold?

      Haleon (LSE:HLN) is back on investor watchlists after fresh returns data showed the shares down about 4% over the past month and roughly 4% over the past 3 months. That shorter term weakness sits against a tougher backdrop, with Haleon’s share price return down 7.8% year to date and the 1 year total shareholder return slipping 7.5%, even though the 3 year total shareholder return remains positive at about 10%. Scan how Haleon compares to other defensive healthcare plays under pressure by...

      Nov 13Yahoo FinanceHLN
      Haleon (LSE:HLN) Stock Looks Reasonable Given Its Cash Flow Upside

      Haleon has delivered a 10.0% share price gain over the past three years, yet the stock is still asking investors to judge whether that journey lines up with the cash it is expected to generate. The open question is whether the current valuation of Haleon stock can be explained by the stream of cash flows implied in its price today. That 10.0% return over three years puts real money on the line for anyone asking whether Haleon's current share price can be backed by the cash it is expected to...

      Nov 13Yahoo FinanceHLN
      Haleon: If Staples Hold Up, The Stock Should Outperform (NYSE:HLN)

      Haleon has underperformed since its 2022 spin from GSK, delivering just over 6% annualized returns, including dividends. Read why HLN stock is a Buy.

      Nov 12Seeking AlphaHLN
      Should you buy shares in Haleon?
      Nov 11The TimesHLN
      Haleon falls Monday, underperforms market
      Nov 9MarketWatchHLN
      Does Reduced Growth Guidance Change The Bull Case For Haleon (LSE:HLN)?

      Haleon has started a share repurchase programme authorised at its April 2026 AGM, allowing buybacks of up to 890,000,000 shares, or about 10% of issued capital, with flexibility to hold shares in treasury, use them for incentives or cancel them before the authority expires in mid 2027. The business now expects organic sales growth around 2.5% for the year and faces a regulatory suspension of Centrum production and sales in China, which is projected to reduce 2027 operating profit by about...

      Nov 5Yahoo FinanceHLN
      Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'
      Nov 4Yahoo FinanceHLN
      Jefferies downgrades Haleon stock rating on margin concerns
      Nov 4Investing.comHLN
      UK Markets Brief: Haleon Shares Crash, Bank of England Prepares to Raise Interest Rates
      Nov 2MorningstarHLN
      Haleon faces calls for a reset as brokers question growth outlook

      Haleon PLC (LSE:HLN, NYSE:HLN) received a Deutsche Bank upgrade despite a target cut, while RBC lowered its target and JPMorgan remained cautious after the group's third-quarter miss and guidance warning. Deutsche Bank moved from 'sell' to 'hold', RBC retained 'sector perform', and JPMorgan...

      Oct 30Yahoo FinanceHLN
      Deutsche Bank upgrades Haleon stock rating on valuation reset
      Oct 30Investing.comHLN
      Haleon Sinks 14% on Growth Downgrade Despite £500 Million Buyback: “Q3 Was Below Our Expectations”
      Oct 29Yahoo FinanceHLN
      London's FTSE 100 rises as Shell boosts energy stocks
      Oct 29ReutersHLNSHEL
      UK's FTSE 100 Rises; Haleon Plummets on Outlook Cut

      London's FTSE 100 closed 0.29% higher on Thursday as investors digested new economic updates and ear

      Oct 29Yahoo FinanceHLN
      Haleon follows Reckitt with guidance cut as cold and flu rates fall
      Oct 29Financial TimesHLN
      Haleon Catches a Cold at the Worst Possible Time
      Oct 29Yahoo FinanceHLN
      Consumer Healthcare Giant Haleon Plunges to 52-Week Low
      Oct 29BenzingaHLN
      Haleon shares tumble as weak flu medicine demand, China woes prompt outlook cut

      Oct 29 (Reuters) - Haleon cut its sales outlook to below market forecasts on Thursday, hurt by weak demand for flu and cold medicines and a regulatory setback in ‌China, sparking the biggest-ever one-day fall in the British consumer health group's shares. The stock, spun off from ‌drugmaker GSK in July 2022, was down nearly 15% by 1300 GMT, making it the worst performer in European and British benchmark indexes.

      Oct 29Yahoo FinanceHLN
      Breakingviews - COMMENTARY: Haleon sales sniffles calls for tough medicine
      Oct 29ReutersHLN
      What Haleon (HLN) Said on Its Q3 Earnings Call
      Oct 29Yahoo FinanceHLN
      EXCLUSIVE: Haleon CEO warns staff of 'difficult choices' ahead after sales miss, memo says
      Oct 29ReutersHLN
      HALEON ADR earnings missed, revenue fell short of estimates
      Oct 29Investing.comHLN
      Haleon (LSE:HLN) Cuts 2026 Organic Revenue Growth Forecast to 2.5% and Announces £500 Million Share Buyback

      Haleon (LSE:HLN) lowered its full-year organic revenue growth forecast on Thursday following third-quarter trading that fell below company expectations, while announcing an additional £500 million share repurchase programme. Shares in the consumer healthcare group declined approximately 12.

      Oct 29Yahoo FinanceHLN
      Haleon Q3 2026 slides: growth misses at 2.6%, guidance cut
      Oct 29Investing.comHLN
      Haleon Q3 Revenue Rises; Full-Year Organic Sales Guidance Cut -- Shares Fall Pre-Bell
      Oct 29Yahoo FinanceHLN
      UK's Haleon slides as weak flu season, China hit prompt outlook cut
      Oct 29ReutersHLN
      Haleon Shares Dive After Advil Maker Cuts Guidance

      Performance was held back by weaker sales in cough, cold and flu products, particularly with lower orders in North America.

      Oct 29WSJHLN
      Why is Haleon stock plunging today?
      Oct 29Investing.comHLN
      Haleon shares drop as poor cold and flu sales hit forecasts
      Oct 29The TimesHLN
      Haleon shares drop on cut in forecasts after poor cold and flu sales
      Oct 29The TimesHLN
      Haleon trims 2026 growth outlook as weaker cold and flu demand prompts £500 mln
      Oct 29Investing.comHLN
      Haleon launches £500 million share buyback programme
      Oct 29Yahoo FinanceHLN
      Haleon shares slide after targets cut due to weak cold and flu demand

      The FTSE 100 company said revenues grew by 2.5% to £2.87 billion for the three months to September 30, compared with the same period last year.

      Oct 29Yahoo FinanceHLN
      Haleon (LSE:HLN) Has Investors Asking A Bigger Question
      Oct 28Yahoo FinanceHLN
      Haleon (LSE:HLN) Appoints Deep Malde To Drive Expert Marketing And Transformation
      Oct 28Yahoo FinanceHLN
      Haleon climbs Thursday, outperforms market
      Oct 22MarketWatchHLN
      UBS says early flu pick-up could lift 2027 earnings at Reckitt and Haleon
      Oct 20Yahoo FinanceHLN
      Will Headache Remedy Launch Change Haleon's (LSE:HLN) Narrative
      Oct 18Yahoo FinanceHLN
      Haleon rallies Thursday, outperforms market
      Oct 15MarketWatchHLN
      Is Haleon (LSE:HLN) Using Excedrin’s Nostalgic Game To Redefine Consumer Health Brand Moats?
      Oct 15Yahoo FinanceHLN
      Haleon advances Wednesday, outperforms market
      Oct 14MarketWatchHLN
      Is Haleon (LSE:HLN) Undervalued After A 11% Three Year Return?
      Oct 14Yahoo FinanceHLN
      Haleon (LSE:HLN) Unveils Excedrin Push, Is The Valuation Gap An Opportunity?
      Oct 14Yahoo FinanceHLN
      Haleon advances Monday, outperforms market
      Oct 12MarketWatchHLN
      Haleon advances Friday, outperforms market
      Oct 9MarketWatchHLN
      Goldman Sachs Sticks to Their Buy Rating for Haleon PLC (HLN)

      Detailed price information for Haleon Plc (HLN-N) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailHLN
      Barclays Reaffirms Their Buy Rating on Haleon PLC (HLN)

      Detailed price information for Haleon Plc (HLN-N) from The Globe and Mail including charting and trades.

      Oct 8The Globe and MailHLN
      Haleon rallies Wednesday, outperforms market
      Oct 7MarketWatchHLN
      Unilever on JP Morgan positive watch as Haleon faces caution

      Unilever PLC (LSE:ULVR) is on JP Morgan's 'positive watch', and Haleon PLC (LSE:HLN, NYSE:HLN) on 'negative watch', ahead of third-quarter reporting by European consumer staples companies. The note adds Givaudan to positive watch alongside Unilever, Heineken N.V. (AEX:HEIA) and Danone...

      Oct 5Yahoo FinanceHLNUL
      Haleon slips Thursday, underperforms market
      Oct 1MarketWatchHLN

      This is the newest page. Registered accounts read further back.